Cargando…
Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study
BACKGROUND: Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that has shown anti-inflammatory activity and neuroprotection and has been used for the treatment of compressive syndromes. The aim of this study is to investigate the clinical and electrophysiological effects of conservative...
Autores principales: | Faig-Martí, Jordi, Martínez-Catassús, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685977/ https://www.ncbi.nlm.nih.gov/pubmed/28299455 http://dx.doi.org/10.1007/s10195-017-0453-z |
Ejemplares similares
-
Measuring the placebo effect in carpal tunnel syndrome
por: Faig-Martí, Jordi, et al.
Publicado: (2020) -
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015) -
The usefulness of ultrasonography to diagnose the early stage of carpal tunnel syndrome in proximal to the carpal tunnel inlet: A prospective study
por: Bang, Myeonghwan, et al.
Publicado: (2019) -
Ultrasonography Findings of the Carpal Tunnel after Endoscopic Carpal Tunnel Release for Carpal Tunnel Syndrome
por: Ng, Alex Wing Hung, et al.
Publicado: (2021) -
Ultrasound assessment of carpal tunnel in rheumatoid arthritis and idiopathic carpal tunnel syndrome
por: Smerilli, Gianluca, et al.
Publicado: (2020)